Companies: 10,795·Total market cap: $144.5T

Entera Bio Ltd.

Entera Bio Ltd.

ENTXNASDAQHealthcare● Active

$1.20

+$0.02(+1.69%)

Market Cap$59148240

P/E Ratio—

52W High$3.22

52W Low$0.91

Avg Volume166K

Open$1.17

Beta1.49

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Entera Bio Ltd.（ENTX）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ENTX · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.26Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding46.2MShares outstanding history

Next EarningsAug 14, 2026Est.Earnings history

探索 Entera Bio Ltd. 数据

分析师预测$— · Buy

股息不分红

营收$42000-76.80%

盈利EPS $-0.25+0.00%

财务快照

FY 2025Revenue$42000.00▼ 76.80% YoY

202320242025

FY 2025Net Income-$11.4M▼ 19.89% YoY

202320242025

FY 2025EPS$-0.25▲ +0.00% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$12.4MEPS: $-0.26View income statement →

分析师评级与目标价

Buy4 位分析师

Strong Buy

0

Buy

4

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$1.20Current

$—Avg Target

$—High

合计: 4 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Entera Bio Ltd.

$1.20+1.69%$59.1M #2

Acumen Pharmaceuticals, Inc.

$2.17+0.93%$131.4M #3

$3.14-2.79%$130.8M #4

Anixa Biosciences, Inc.

$2.46-0.81%$82.5M #5

TuHURA Biosciences, Inc.

$2.05+4.07%$130.2M #6

Inovio Pharmaceuticals, Inc.

$1.09+1.87%$58.4M

股票表现

1D+1.69%

1W-1.64%

1M-7.69%

3M-4.00%

YTD-38.14%

1Y-43.40%

5Y-68.59%

关于 Entera Bio Ltd.

CEOMiranda J. Toledano

IPO DateJun 28, 2018

Employees18

CountryIL

Websiteenterabio.com

Entera Bio Ltd. is a biopharmaceutical firm in the clinical development phase, dedicated to creating and marketing oral medications composed of large molecules, addressing medical conditions that curr…

Biotechnology HealthcareNASDAQIL

关于股票概览与关键数据

Entera Bio Ltd.（ENTX）是 Biotechnology 行业的 Healthcare 类公司，于 Jun 28, 2018 在 NASDAQ 上市。截至最近交易日，ENTX 股价为 $1.20，市值约为 $59.1M。过去12个月累计回报 -43.40%，年初至今回报 -38.14%。

根据 4 位华尔街分析师，Entera Bio Ltd. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 Entera Bio Ltd. 营收 $42000.00，净利润 -$11.4M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Entera Bio Ltd.（ENTX）股价为 $1.20，在 NASDAQ 上市，52周区间为 $0.91 – $3.22。

ENTX 最新股价ENTX quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议